CD
BMEZ icon

Chapin Davis’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Chapin Davis’s Portfolio BMEZ Stock Details BMEZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$420K Sell
25,120
-1,334
-5% -$21.5K 0.08% 157
2026
Q2 		$406K Buy
26,454
+400
+2% +$5.75K 0.07% 166
2026
Q1 		$374K Sell
26,054
-1,551
-6% -$23K 0.08% 181
2025
Q4 		$415K Hold
27,605
– – 0.1% 162
2025
Q3 		$398K Buy
27,605
+849
+3% +$12.1K 0.1% 164
2025
Q2 		$382K Buy
26,756
+6,400
+31% +$91.5K 0.11% 161
2025
Q1 		$303K Buy
20,356
+500
+3% +$7.82K 0.1% 162
2024
Q4 		$315K Hold
19,856
– – 0.1% 166
2024
Q3 		$315K Sell
19,856
-2,194
-10% -$34.6K 0.1% 167
2024
Q2 		$339K Hold
22,050
– – 0.12% 157
2024
Q1 		$361K Buy
22,050
+5,500
+33% +$86.7K 0.13% 154
2023
Q4 		$242K Hold
16,550
– – 0.1% 180
2023
Q3 		$238K Hold
16,550
– – 0.11% 159
2023
Q2 		$272K Hold
16,550
– – 0.13% 156
2023
Q1 		$277K Buy
16,550
+1,150
+7% +$18.5K 0.14% 158
2022
Q4 		$238K Buy
+15,400
New +$238K 0.14% 158

Other funds holding BMEZ

Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
Independent Financial Group
Independent Financial Group San Diego, California $5.51B AUM 33.52% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $2.57B AUM 28.13% 1-Year Est. Return
CoreCap Advisors
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Chapin Davis's BMEZ Position: Q3 2026 in Review

Chapin Davis reduced its BlackRock Health Sciences Trust II (BMEZ) stake by 5% in Q3 2026, selling an estimated $21.5K and leaving 25,120 shares worth $420K. The position accounts for 0.08% of the portfolio, ranked #157.

Chapin Davis first reported a position in BMEZ in Q4 2022 and has held it in 16 quarters since. 5 funds tracked by Wall St. Rank hold BMEZ as of Q3 2026.

  • Chapin Davis held 25,120 shares of BlackRock Health Sciences Trust II worth $420K as of Q3 2026.
  • Chapin Davis sold 1,334 BlackRock Health Sciences Trust II shares in Q3 2026, an estimated $21.5K.
  • BlackRock Health Sciences Trust II made up 0.08% of Chapin Davis's portfolio in Q3 2026, its #157 holding.
  • Chapin Davis first reported a position in BlackRock Health Sciences Trust II in Q4 2022 and has held it in 16 quarters since.
  • 5 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q3 2026.

Based on Chapin Davis's 13F filing for Q3 2026, filed 9 Oct 2026.